Nile Pharmaceuticals and Chemical Industries Company Share Price
Stocks
NIPH
EGS38331C012
Pharmaceuticals
|
End-of-day quote
Egyptian Exchange
09/11/2026
|
5-day change | 1st Jan Change | ||
| 303.61 EGP | +5.42% |
|
+15.43% | +202.94% |
| Market Cap | 1.52TCr 28Cr 25Cr 23Cr 21Cr 40Cr 2.64TCr 41Cr 276.81Cr 110.33Cr 1.41TCr 105.74Cr 103.48Cr 4.45TCr | P/E 2025 |
11.7x | P/E 2026 | 32x |
|---|---|---|---|---|---|
| Enterprise Value | 1.67TCr 31Cr 28Cr 25Cr 23Cr 44Cr 2.91TCr 45Cr 304.84Cr 121.5Cr 1.56TCr 116.45Cr 113.96Cr 4.9TCr | EV / Sales 2025 |
1.89x | EV / Sales 2026 | 4.56x |
| Free-Float |
20.38% | Yield 2025 |
4.1% | Yield 2026 | - |
| 1 day | +5.42% | ||
| 1 week | +15.43% | ||
| Current month | +7.28% | ||
| 1 month | -3.77% | ||
| 3 months | -15.43% | ||
| 6 months | +92.28% | ||
| Current year | +202.94% |
| 1 week | 268 |  | 312 |
| 1 month | 205 | | 318.8 |
| Current year | 87 | | 516.96 |
| 1 year | 87 | | 516.96 |
| 3 years | 41.3 | | 516.96 |
| 5 years | 24 | | 516.96 |
| 10 years | 8.51 | | 516.96 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
| Director of Finance/CFO | - | - | |
| Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | - | |
| Director/Board Member | - | - | |
| Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.42% | +15.43% | +183.54% | +323.09% | 28Cr | |
| +4.28% | +0.07% | +52.75% | +138.78% | 1,25800Cr | |
| +2.13% | +4.27% | +51.21% | +91.36% | 68TCr | |
| +0.68% | +1.54% | +33.83% | +112.47% | 52TCr | |
| -0.37% | +2.10% | +43.13% | +68.62% | 39TCr | |
| +1.38% | +0.27% | +72.42% | +45.30% | 37TCr | |
| +0.35% | +1.99% | +31.23% | +59.93% | 31TCr | |
| -0.55% | +1.75% | +6.66% | +38.75% | 29TCr | |
| +1.04% | -0.05% | +45.29% | +76.18% | 25TCr | |
| +1.46% | -0.59% | +42.48% | +125.82% | 21TCr | |
| Average | +0.95% | +2.03% | +56.25% | +108.03% | 43TCr | |
| Weighted average by Cap. | +0.47% | +1.18% | +45.38% | +96.80% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 128.96Cr 2.39Cr 2.14Cr 1.97Cr 1.78Cr 3.38Cr 224.32Cr 3.46Cr 24Cr 9.37Cr 120.1Cr 8.98Cr 8.79Cr 378.25Cr | 213.39Cr 3.96Cr 3.53Cr 3.25Cr 2.95Cr 5.59Cr 371.2Cr 5.73Cr 39Cr 16Cr 198.73Cr 15Cr 15Cr 625.92Cr |
| Net income | 13Cr 23.33L 20.83L 19.16L 17.39L 32.96L 22Cr 33.78L 2.29Cr 91.38L 12Cr 87.58L 85.7L 37Cr | 26Cr 47.58L 42.47L 39.08L 35.47L 67.21L 45Cr 68.88L 4.67Cr 1.86Cr 24Cr 1.79Cr 1.75Cr 75Cr |
| Net Debt | 97Cr 1.8Cr 1.6Cr 1.47Cr 1.34Cr 2.54Cr 168.28Cr 2.6Cr 18Cr 7.03Cr 90Cr 6.74Cr 6.59Cr 283.74Cr | 153.71Cr 2.85Cr 2.55Cr 2.34Cr 2.13Cr 4.03Cr 267.38Cr 4.13Cr 28Cr 11Cr 143.15Cr 11Cr 10Cr 450.86Cr |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/26/09 | EGP 303.61 | +5.42% | 8,48,099 |
| 08/26/08 | EGP 288.01 | +2.49% | 5,88,949 |
| 05/26/05 | EGP 281.00 | +1.08% | 4,69,435 |
| 04/26/04 | EGP 278.00 | +1.46% | 5,13,510 |
| 03/26/03 | EGP 274.00 | +4.17% | 4,48,330 |
- Stock Market
- Stocks
- NIPH Stock
Select your edition
All financial news and data tailored to specific country editions
